AxoGen Operating Margin 2010-2024 | AXGN
Current and historical operating margin for AxoGen (AXGN) over the last 10 years. The current operating profit margin for AxoGen as of December 31, 2024 is -5.32%.
| AxoGen Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-12-31 |
$0.19B |
$0.00B |
-1.60% |
| 2024-09-30 |
$0.18B |
$-0.01B |
-4.42% |
| 2024-06-30 |
$0.17B |
$-0.01B |
-6.94% |
| 2024-03-31 |
$0.16B |
$-0.02B |
-11.66% |
| 2023-12-31 |
$0.16B |
$-0.02B |
-13.21% |
| 2023-09-30 |
$0.15B |
$-0.02B |
-15.79% |
| 2023-06-30 |
$0.15B |
$-0.03B |
-16.89% |
| 2023-03-31 |
$0.14B |
$-0.03B |
-18.06% |
| 2022-12-31 |
$0.14B |
$-0.03B |
-21.74% |
| 2022-09-30 |
$0.13B |
$-0.03B |
-21.64% |
| 2022-06-30 |
$0.13B |
$-0.03B |
-24.22% |
| 2022-03-31 |
$0.13B |
$-0.03B |
-23.44% |
| 2021-12-31 |
$0.13B |
$-0.03B |
-19.53% |
| 2021-09-30 |
$0.13B |
$-0.03B |
-19.53% |
| 2021-06-30 |
$0.13B |
$-0.02B |
-14.62% |
| 2021-03-31 |
$0.12B |
$-0.02B |
-16.95% |
| 2020-12-31 |
$0.11B |
$-0.02B |
-20.72% |
| 2020-09-30 |
$0.11B |
$-0.03B |
-23.36% |
| 2020-06-30 |
$0.10B |
$-0.03B |
-29.13% |
| 2020-03-31 |
$0.11B |
$-0.03B |
-27.78% |
| 2019-12-31 |
$0.11B |
$-0.03B |
-28.97% |
| 2019-09-30 |
$0.10B |
$-0.03B |
-29.41% |
| 2019-06-30 |
$0.10B |
$-0.03B |
-30.21% |
| 2019-03-31 |
$0.09B |
$-0.03B |
-28.89% |
| 2018-12-31 |
$0.08B |
$-0.02B |
-25.00% |
| 2018-09-30 |
$0.08B |
$-0.02B |
-21.79% |
| 2018-06-30 |
$0.07B |
$-0.01B |
-18.31% |
| 2018-03-31 |
$0.07B |
$-0.01B |
-13.85% |
| 2017-12-31 |
$0.06B |
$-0.01B |
-11.67% |
| 2017-09-30 |
$0.05B |
$-0.01B |
-14.81% |
| 2017-06-30 |
$0.05B |
$-0.01B |
-16.33% |
| 2017-03-31 |
$0.04B |
$-0.01B |
-20.45% |
| 2016-12-31 |
$0.04B |
$-0.01B |
-22.50% |
| 2016-09-30 |
$0.04B |
$-0.01B |
-24.32% |
| 2016-06-30 |
$0.03B |
$-0.01B |
-29.41% |
| 2016-03-31 |
$0.03B |
$-0.01B |
-33.33% |
| 2015-12-31 |
$0.03B |
$-0.01B |
-37.04% |
| 2015-09-30 |
$0.02B |
$-0.01B |
-41.67% |
| 2015-06-30 |
$0.02B |
$-0.01B |
-47.62% |
| 2015-03-31 |
$0.02B |
$-0.01B |
-52.63% |
| 2014-12-31 |
$0.02B |
$-0.01B |
-58.82% |
| 2014-09-30 |
$0.02B |
$-0.01B |
-66.67% |
| 2014-06-30 |
$0.01B |
$-0.01B |
-76.92% |
| 2014-03-31 |
$0.01B |
$-0.01B |
-83.33% |
| 2013-12-31 |
$0.01B |
$-0.01B |
-81.82% |
| 2013-09-30 |
$0.01B |
$-0.01B |
-80.00% |
| 2013-06-30 |
$0.01B |
$-0.01B |
-88.89% |
| 2013-03-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2012-12-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2012-09-30 |
$0.01B |
$-0.01B |
-114.29% |
| 2012-06-30 |
$0.01B |
$-0.01B |
-150.00% |
| 2012-03-31 |
$0.01B |
$-0.01B |
-160.00% |
| 2011-12-31 |
$0.00B |
$-0.01B |
-175.00% |
| 2011-09-30 |
$0.01B |
$-0.01B |
-160.00% |
| 2011-06-30 |
$0.01B |
$-0.01B |
-120.00% |
| 2011-03-31 |
$0.00B |
$-0.01B |
-125.00% |
| 2010-12-31 |
$0.00B |
$0.00B |
-133.33% |
| 2010-09-30 |
$0.03B |
$0.02B |
60.00% |
| 2010-06-30 |
$0.02B |
$0.02B |
66.67% |
| 2010-03-31 |
$0.03B |
$0.02B |
64.00% |
| 2009-12-31 |
$0.03B |
$0.02B |
64.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.750B |
$0.187B |
|
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.
|
